Borregaard’s operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, while BioSolutions and Fine Chemicals had lower results compared with the 4th quarter of 2024. In BioSolutions, high deliveries of biovanillin and sustained growth in sales to agriculture were more than offset by increased costs. For BioMaterials, higher sales prices and lower wood and energy costs, more than comp ...

NORTHBROOK, Ill.--(BUSINESS WIRE)--CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer of hydrogen and nitrogen products, and POET, the world's largest producer of biofuels, have launched a pilot project with major agriculture co-operatives to jointly develop a low-carbon fertilizers supply chain. The goal of the pilot is to demonstrate how the use of low carbon nitrogen fertilizer can substantially reduce the carbon intensity of corn and enable the production of low carbon ethanol for us ...

Financial Performance - Operating revenues increased to NOK 2,045 million in Q2 2025, up from NOK 1,949 million in the same period last year [1] - EBITDA reached NOK 522 million, compared to NOK 510 million in the previous year [1] - Profit before tax was NOK 326 million, slightly up from NOK 322 million [2] - Earnings per share increased to NOK 2.56 from NOK 2.45 [2] Segment Performance - BioSolutions saw improved results driven by continued growth in sales to agriculture [2][3] - BioMaterials experienced an increase in results due to higher sales prices, improved product mix, and increased sales volume, although this was partly offset by higher wood costs [2] - Fine Chemicals reported a weaker result primarily due to lower sales prices for bioethanol [2] Market Conditions - Positive net currency effects were noted across all areas [2] - The company’s President and CEO highlighted strong sales to agriculture and price increases for specialty cellulose as key drivers for improved results in BioSolutions and BioMaterials [3]

Group 1: Leadership Transition - Tom Erik Foss-Jacobsen has been appointed as the new CEO of Borregaard ASA, effective from August 1, 2025, succeeding Per A. Sørlie who will retire after 26 years in the role [1][5] - Helge Aasen, chair of Borregaard's Board of Directors, expressed confidence in Foss-Jacobsen's leadership capabilities, highlighting his in-depth understanding of the business and strong results in previous roles [2][5] - Per A. Sørlie has been with Borregaard for 35 years, contributing significantly to the company's transformation into a bio-based specialty chemicals firm and driving profit growth since its listing on the Oslo Stock Exchange in 2012 [6] Group 2: Background of Tom Erik Foss-Jacobsen - Foss-Jacobsen is currently the Executive Vice President and head of BioSolutions, a position he has held since 2019, and has over 25 years of experience at Borregaard, including 21 years in leadership roles [3] - He holds a master's degree in international marketing and strategy and a bachelor's degree in civil engineering, indicating a strong educational background relevant to his new role [3] Group 3: Future Outlook - Foss-Jacobsen expressed a commitment to driving sustainable growth and creating value for Borregaard and its stakeholders, indicating a focus on the company's strategic objectives [5] - The Board will grant Foss-Jacobsen stock options upon his accession, aligning his interests with the long-term performance of the company [7]